scispace - formally typeset
A

Anna R. Moverley

Researcher at University of Leeds

Publications -  14
Citations -  656

Anna R. Moverley is an academic researcher from University of Leeds. The author has contributed to research in topics: Psoriatic arthritis & Randomized controlled trial. The author has an hindex of 8, co-authored 14 publications receiving 556 citations. Previous affiliations of Anna R. Moverley include Leeds Teaching Hospitals NHS Trust & Scarborough General Hospital.

Papers
More filters
Journal ArticleDOI

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

TL;DR: Tight control of psoriatic arthritis disease activity through a treat-to-target approach significantly improves joint outcomes for newly diagnosed patients, with no unexpected serious adverse events reported.
Journal ArticleDOI

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis

TL;DR: The TICOPA trial will provide direct evidence as to whether the use of early and intensive treatment in PsA in routine clinical care leads to an improvement in patients’ disease activity and a reduction in radiological joint damage.
Journal ArticleDOI

Is There Subclinical Synovitis in Early Psoriatic Arthritis? A Clinical Comparison With Gray‐Scale and Power Doppler Ultrasound

TL;DR: Clinical examination and ultrasound findings in an early PsA cohort are compared and subclinical inflammation using modern imaging techniques is demonstrated.
Journal ArticleDOI

It’s not just the joints, it’s the whole thing: qualitative analysis of patients’ experience of flare in psoriatic arthritis

TL;DR: It is clear that flare in PsA is more than a swollen or tender joint count as measured in clinical practice, and a number of components of flare are identified from the patient perspective.
Journal ArticleDOI

A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)).

TL;DR: A pilot study to test the feasibility of drug withdrawal from patients with psoriatic arthritis, in stable low disease state, found that partial treatment withdrawal, possibly including a patient preference arm, is recommended.